These success, along with a prior report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the strategy of concentrating on ACKR3 as a novel approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. Name your collection: Name https://edwardv160dpf7.bligblogging.com/profile